Fredun Pharmaceuticals Limited (FREDUN) reported revenue of ₹228 Cr and net profit of ₹13.13 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
FREDUN fundamentals, Fundamental score 77/100
The statements below are read from Fredun Pharmaceuticals Limited’s filed results, 7 filed quarters and 2 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 5, 2026
Quarterly resultsConsolidated
₹ Cr
Sep2024
Mar2025
Jun2025
Sep2025
Dec2025
Mar2026
Jun2026Latest
YoYlatest
Sales
0.00
165
119
144
160
210
228
+90.7%
0.00
150
103
123
135
184
196
+90.1%
Operating profit
0.00
15.3
16.5
20.6
25.3
26.2
32.2
+95.0%
OPM %
—
9.2%
13.9%
14.4%
15.8%
12.5%
14.2%
+0.3 pp
Other income
0.00
1.97
0.45
1.71
1.00
2.64
0.49
+8.9%
Interest
0.00
8.15
6.53
7.73
10.5
14.5
8.62
+31.9%
Depreciation
0.00
1.84
1.42
1.89
1.78
3.15
3.57
+151.6%
Profit before tax
0.00
7.26
9.04
12.7
14.0
11.2
20.6
+127.3%
Tax %
n/a (loss)
17.4%
25.2%
25.8%
25.2%
4.2%
36.1%
+10.9 pp
Net profit
0.00
6.00
6.77
9.43
10.5
10.8
13.1
+94.1%
EPS (₹)
0.00
12.71
14.33
19.98
19.53
19.70
23.82
+66.2%
One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split · n/a (loss) = tax rate undefined on a loss↔ scroll for earlier quarters
Revenue & net profit trend
last 7 quarters
RevenueNet profit
Revenue & net profit — Consolidated7 quarters
Segment results
Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.
Forensic checksauto-scanned from the filing
Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.
How results moved the priceEOD reaction on the session the market could trade the filing
Avg absolute result-day move ±6.6%· EPS surprise: no estimates source· 4 earlier quarters have no dated filing on record
Q1'27filed Wed 5 Aug 13:49 · traded that sessiongap +1.0%close +18.3%
Q4'26filed Mon 25 May 22:10 · first tradeable session Tue 26 Maygap −0.2%close +0.6%
Q3'26filed Mon 9 Feb 20:15 · first tradeable session Tue 10 Febgap +2.3%close −0.8%
